4-Bromo-N-(3-chloro-2-methylphenyl)benzenesulfonamide

Catalog No. :
ACSDYM047
CAS No. :
311328-85-5
Molecular Formula :
C13H11BrClNO2S
Molecular Weight :
360.66

IUPAC Name:4-bromo-N-(3-chloro-2-methylphenyl)benzenesulfonamide

4-Bromo-N-(3-chloro-2-methylphenyl)benzenesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$56.00Login to see priceInquiryInquiry
1g95%$159.00Login to see priceIn stockInquiry
5g95%$611.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-N-(3-chloro-2-methylphenyl)benzenesulfonamide
IUPAC Name4-bromo-N-(3-chloro-2-methylphenyl)benzenesulfonamide
MDL No.MFCD00586864
Molecular FormulaC13H11BrClNO2S
Molecular Weight360.66
SMILESCC1=C(C=CC=C1Cl)NS(=O)(C2=CC=C(C=C2)Br)=O
InChI KeyHKOUIPZCTZESCA-UHFFFAOYSA-N
Synonym4-bromo-N-(3-chloro-2-methylphenyl)benzenesulfonamide;Benzenesulfonamide, 4-bromo-N-(3-chloro-2-methylphenyl)-
CAS No.311328-85-5
PubChem CID1041289

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACSDYM047 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBTWK016 route compound structure diagram
    ACBTWK01687-60-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSDYM047 route product structure diagram
    ACSDYM047311328-85-5 In Stock
Inquiry

2. ACSDYM047 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBTWK016 route compound structure diagram
    ACBTWK01687-60-5 In Stock
  2. Plus
  3. ACDCXW026 route compound structure diagram
    ACDCXW026138-36-3 In Stock
  4. Then
  5. ACSDYM047 route product structure diagram
    ACSDYM047311328-85-5 In Stock
Inquiry

Comments (0)